| Ytd | 12.10% | |
| 1y | 0.16% |
| Open | 88.94 | Prev Close | 89.08 | Low | 87.52 | High | 89.20 | Mkt Cap | 16.93B |
| Vol | 50.47K | Avg Vol | 443.92K | EPS | 10.84 | P/E | 8.22 | Forward P/E | 0.01 |
| Beta | 0.99 | Short Ratio | 3.30 | Inst. Own | 47.82% | Dividend | 6.97 | Div Yield | 7.93 |
| Ex Div Date | 06-12 | Earning | 08-10 | 50-d Avg | 87.04 | 200-d Avg | 79.31 | 1yr Est | 98.02 |
Amova Asset Management Americas Inc. cut its stake in Joint Stock Company Kaspi.kz Sponsored ADR (NA
Here is how Ingram Micro (INGM) and Joint Stock Company Kaspi.kz Sponsored ADR (KSPI) have performed
ALMATY, Kazakhstan, July 15, 2026 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”) (Nas
Joint Stock Company Kaspi.kz ("Kaspi.kz") (NASDAQ:KSPI) today announced that it has received
Kaspi.kz (NASDAQ:KSPI) reported quarterly earnings of $2.77 per share which beat the analyst consens
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss